increased

loans and a revision of actuarial assumptions. The SCR increased from €102m to €128m over the reporting period. This increase can again be explained by the new acquisition and thus additional risks on the balance sheet. On the other hand, the rebalancing exercise performed by the Company in 2024, moving government bonds into corporate bonds also caused an increase in the market risk and thus the Solvency Capital Requirements. The absolute MCR increased in line with the SCR from €46m to €57m

reporting period from €312,9m to € 372,1m. This increase was principally due to the acquisition of the AXA portfolio in October 2022 where a capital injection of €50m was carried out. The SCR increased from € 127,4m to € 147,7m over the reporting period... Profile. Valuation for Solvency Purposes The Company’s balance sheet has significantly increased in 2022 following the closing of AXA transaction st the 31 of October 2022. The asset allocation evolves in accordance with the target asset allocation of

. The SCR increased from € 3.0m to € 127.4m over the reporting period. This increase is a direct consequence of the acquisition of the Integrale and the Allianz books. these acquisitions increased the balance sheet, both on asset and liability side.... Valuation for Solvency Purposes The Company’s balance sheet has significantly increased in terms of assets classes presented following the recent acquisitions. The majority of assets comprises mainly of corporate and government bonds, collective investment

a rising interest environment and normalization in inflation rates. The OLO 10 year rate, representing the returns on 10 years Belgian government bonds, increased from 2.6% in December 2023 to c.3.4% in December 2025. At the same time, inflation rates

% Ratio of Own Funds to MCR 841% 560% Eligible Own funds increased significantly over the reporting period from €372,1m to € 386,4m. The SCR decreased from € 147,7m to € 102,1m over the reporting period. This decrease can be explained on the one hand by... decreased in line with the SCR from € 66,5m to €45,9m compared to the year-end 2022. The solvency ratio of the Company increased from 252% to 378% over the reporting period. Further details of the Company’s Own Funds and SCR are provided in Section E

. For certain risks, failure to follow defined procedures could result in individual colleagues being directly liable to prosecution or regulatory penalties. 2.2.4 Failing to comply with this Policy can result in increased costs, wasted management time